Efficacy and safety of low-intensity chemotherapy combined with immunotherapy in elderly patients with locally advanced and metastatic non–small cell lung cancer: a retrospective analysis
Abstract For advanced non-small cell lung cancer (NSCLC) lacking driver mutations, immunotherapy combined with chemotherapy is a standard treatment; however, elderly patients frequently exhibit poor tolerance to standard chemotherapy and derive limited benefit from immunotherapy alone. Thus, this re...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2026-04-01
|
| Col·lecció: | BMC Cancer |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s12885-026-15943-1 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|